Novartis AG (SWX:NOVN)

Novartis AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,066	11,459	13,393	7,517	12,407	9,658
Short-Term Investments	112	1,892	680	11,209	15,817	1,746
Cash & Short-Term Investments	7,178	13,351	14,073	18,726	28,224	11,404
Cash Growth	-26.02%	-5.13%	-24.85%	-33.65%	147.49%	0.53%
Accounts Receivable	8,596	7,423	7,107	8,066	8,005	8,217
Other Receivables	129	1,939	2,140	1,735	1,558	1,746
Receivables	8,725	9,362	9,247	9,801	9,563	9,963
Inventory	5,829	5,723	5,913	7,175	6,666	7,131
Prepaid Expenses	-	985	764	911	1,102	943
Other Current Assets	3,376	283	484	297	163	232
Total Current Assets	25,108	29,704	30,481	36,910	45,718	29,673
Property, Plant & Equipment	11,087	10,873	10,924	12,195	13,106	13,939
Long-Term Investments	1,409	1,128	1,827	1,606	2,268	11,611
Goodwill	24,965	24,756	23,341	29,301	29,595	29,999
Other Intangible Assets	27,476	26,915	26,879	27,223	28,683	32,109
Long-Term Accounts Receivable	-	54	104	59	70	83
Long-Term Deferred Tax Assets	5,099	4,359	4,309	3,739	3,743	3,933
Long-Term Deferred Charges	-	-	-	4,421	5,499	4,700
Other Long-Term Assets	4,797	4,355	1,966	1,914	3,035	1,642
Total Assets	99,941	102,246	99,945	117,453	131,795	127,778
Accounts Payable	4,261	4,572	4,926	5,146	5,553	5,403
Accrued Expenses	-	5,250	5,174	5,387	5,149	5,503
Short-Term Debt	-	4,733	3,893	3,635	3,606	7,319
Current Portion of Long-Term Debt	7,801	3,499	2,282	2,296	2,689	2,466
Current Portion of Leases	242	235	230	251	275	286
Current Income Taxes Payable	2,570	1,599	1,893	2,533	2,415	2,458
Current Unearned Revenue	-	127	98	123	123	56
Other Current Liabilities	16,745	8,677	7,894	9,285	10,398	9,568
Total Current Liabilities	31,619	28,692	26,390	28,656	30,208	33,059
Long-Term Debt	21,666	21,366	18,436	20,244	22,902	26,259
Long-Term Leases	1,561	1,568	1,598	1,538	1,621	1,719
Long-Term Deferred Tax Liabilities	2,548	2,419	2,248	2,686	3,070	3,141
Other Long-Term Liabilities	4,095	1,602	1,793	2,267	2,383	2,216
Total Liabilities	61,489	58,120	53,195	58,030	63,973	71,112
Common Stock	766	793	825	890	901	913
Retained Earnings	39,839	46,561	49,649	63,540	70,989	57,157
Treasury Stock	-19	-53	-41	-92	-48	-53
Comprehensive Income & Other	-2,217	-3,255	-3,766	-4,996	-4,187	-1,419
Total Common Equity	38,369	44,046	46,667	59,342	67,655	56,598
Minority Interest	83	80	83	81	167	68
Shareholders' Equity	38,452	44,126	46,750	59,423	67,822	56,666
Total Liabilities & Equity	99,941	102,246	99,945	117,453	131,795	127,778
Total Debt	31,270	31,401	26,439	27,964	31,093	38,049
Net Cash (Debt)	-24,092	-18,050	-12,366	-9,238	-2,869	-26,645
Net Cash Per Share	-11.95	-8.87	-5.91	-4.20	-1.27	-11.60
Filing Date Shares Outstanding	1,959	1,975	2,044	2,120	2,235	2,257
Total Common Shares Outstanding	1,959	1,975	2,044	2,120	2,235	2,257
Working Capital	-6,511	1,012	4,091	8,254	15,510	-3,386
Book Value Per Share	19.58	22.30	22.83	28.00	30.27	25.08
Tangible Book Value	-14,072	-7,625	-3,553	2,818	9,377	-5,510
Tangible Book Value Per Share	-7.18	-3.86	-1.74	1.33	4.20	-2.44
Land	-	376	403	451	492	555
Buildings	-	9,526	10,147	11,396	11,819	12,377
Machinery	-	9,046	9,630	11,842	13,328	14,038
Construction In Progress	-	1,610	1,213	1,184	1,508	1,248

Source: S&P Global Market Intelligence. Standard template. Financial Sources.